Torray Investment Partners LLC Has $1.66 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Torray Investment Partners LLC boosted its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 1.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,356 shares of the medical instruments supplier’s stock after purchasing an additional 13 shares during the quarter. Torray Investment Partners LLC’s holdings in Mettler-Toledo International were worth $1,659,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Huntington National Bank grew its position in Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock valued at $81,000 after acquiring an additional 9 shares during the last quarter. Townsquare Capital LLC grew its holdings in shares of Mettler-Toledo International by 2.0% during the third quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier’s stock worth $693,000 after purchasing an additional 9 shares during the last quarter. M3 Advisory Group LLC grew its holdings in shares of Mettler-Toledo International by 5.8% during the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock worth $202,000 after purchasing an additional 9 shares during the last quarter. Apollon Wealth Management LLC grew its holdings in shares of Mettler-Toledo International by 2.5% during the fourth quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock worth $451,000 after purchasing an additional 9 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC grew its holdings in shares of Mettler-Toledo International by 3.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock worth $374,000 after purchasing an additional 9 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on MTD shares. Evercore ISI boosted their price target on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Stifel Nicolaus reduced their price target on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a report on Monday, November 11th. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a report on Monday, February 10th. Citigroup upgraded Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Finally, Wolfe Research started coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and a consensus target price of $1,368.00.

Mettler-Toledo International Stock Down 0.3 %

Shares of NYSE:MTD opened at $1,269.44 on Tuesday. Mettler-Toledo International Inc. has a twelve month low of $1,142.91 and a twelve month high of $1,546.93. The stock’s 50 day moving average is $1,291.90 and its 200-day moving average is $1,327.92. The firm has a market capitalization of $26.55 billion, a price-to-earnings ratio of 31.32, a PEG ratio of 3.30 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Equities research analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This represents a 99.01 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Christian Magloth sold 790 shares of the company’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares of the company’s stock, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.